We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

Download Mobile App




Brain Buffer System Overcomes Molecular Disturbances in Circadian Clock

By LabMedica International staff writers
Posted on 30 Apr 2014
New evidence has been found for neuronal network communication that helps create a behavioral buffer in the brain to overcome certain disturbances in the molecular level circadian clock rhythms.

Circadian clocks time the sleep/wake cycles as well as many other physiological and cellular pathways to daily 24 hour rhythms. More...
In Drosophila, CLOCK (CLK) and CYCLE (CYC) proteins initiate the circadian system by promoting rhythmic transcription of hundreds of genes. Abolishment of circadian transcriptional oscillations (CTOs) has been shown to abolish circadian function. However, previous studies used manipulations in which the abolishment of the CTOs was very dramatic and involved strong up- or down-regulation of circadian genes.

In this study, a research team led by Sebastian Kadener, assistant professor at the Hebrew University of Jerusalem (Israel), used an innovative genetic approach that enabled them to generate Drosophila melanogaster fruit flies in which the amplitude of CLK-driven CTOs was reduced in a controlled way, either partially (approx. 60%) or strongly (90%). To the best of their knowledge, this is the first time CTOs have been partially damped in a living organism and their role assessed comprehensively.

The researchers postulated that in the brain, communication among the circadian neuronal groups can compensate for the dampened CTOs. This is not surprising, as results from studies on locomotor activity patterns in mammals with core clock protein mutations are among the same lines. However, in mammals the molecular machinery that drives circadian rhythms in the central versus the peripheral oscillators differs, whereas this does not seem to be the case in flies. Yet, in this study, the partial decrease in the amplitude of CTOs led to impaired function of circadian outputs in peripheral functions but did not significantly affect circadian locomotor behavior. This suggests that the clock in the brain has a specific compensatory mechanism. Moreover, flies with reduced CTOs that also had impaired circadian neuronal communication displayed aberrant circadian behavior rhythms.

The partially reduced CTOs led to low amplitude circadian protein oscillations (CPOs) that were not sufficient to drive outputs of peripheral oscillators, while circadian rhythms in locomotor activity were resistant to these partial reductions. This resilience of the brain oscillator was found to depend on communication among circadian neurons in the brain. Indeed, the capacity of the brain oscillator to overcome the low amplitude CTOs depends on the action of the neuropeptide PDF and on the pdf-expressing cells having equal or higher amplitude of CTOs than the rest of the circadian neuronal groups in the brain.

These findings support the idea of network buffering mechanisms that allows the brain to drive robust behavioral circadian rhythms even with low amplitude molecular oscillations. Therefore, in addition to revealing the importance of high amplitude CTOs for cell-autonomous circadian timekeeping, this work demonstrates that the brain's circadian neuronal network has an essential system that protects against disturbances in circadian transcription in the brain.

The study, by Weiss R. et al., was described in the journal PLOS Genetics, published April 3, 2014.

Related Links:

Hebrew University of Jerusalem



Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
βeta-Hydroxybutyrate Reagent
β-Hydroxybutyrate LiquiColor®
Platinum Member
Integrated Biochemical & Immunological System
Biolumi CX Solution X10+C10
Gold Member
Clinical Chemistry Assay
Sorbitol Dehydrogenase (SDH)
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Graphical overview of the study design and colorectal cancer risk stratification using blood-detected mosaic chromosomal alterations (mCAs). The schematic summarizes mCA detection and genomic features, factors associated with mCA carriage, and the integration of mCAs with germline polygenic risk and lifestyle factors for colorectal cancer risk assessment. (Image Credit: ©Science Bulletin)

Blood-Detected Chromosomal Changes May Refine Colorectal Cancer Risk Assessment

Colorectal cancer is among the most common cancers worldwide and a leading cause of cancer-related mortality. Identifying individuals at increased risk could help guide more targeted screening and prevention... Read more

Hematology

view channel
Image: These new ANC reference ranges can help clinicians more accurately interpret neutrophil counts, reduce unnecessary testing and treatment interruptions, and help support more equitable care. (Photo courtesy of the American Society of Hematology)

New Reference Ranges Clarify Normal Neutrophil Counts in Duffy-Null Patients

Duffy-null status is a common genetic trait associated with naturally lower circulating white blood cell counts. It affects about 10% of the U.S. population and more than 66% of people with African or... Read more

Immunology

view channel
Image: The panel expands Cepheid’s respiratory testing portfolio on the GeneXpert platform, offering laboratories greater flexibility in selecting tests based on clinical needs. (Photo courtesy of Cepheid)

Multiplex PCR Test Gains CE Marking to Support Respiratory Infection Diagnosis

Acute respiratory infections often present with overlapping symptoms, making it difficult to distinguish between viral and bacterial causes. Seasonal surges of influenza-like illness in Europe further... Read more

Microbiology

view channel
Image: VITEK PRO combines microbial identification and antimicrobial susceptibility testing on a single platform to support routine microbiology workflows and antibiotic selection. (Photo courtesy of bioMérieux)

Automated Microbial Identification and Susceptibility System Gains FDA Clearance

Antimicrobial resistance (AMR) is a leading global public health threat, causing an estimated 1.27 million deaths annually. The growing challenge of diagnosing and treating resistant infections highlights... Read more

Pathology

view channel
AI: Artificial intelligence; CNN: Convolutional neural networks; ResNet: Residual neural network. (Xing-hua Gao from The First Hospital of China Medical University, China Image Source Link: https://www.ovid.com/jnls/cmj/fulltext/10.1097/cm9.0000000000004154~deep-learning-based-computational-pathology-technologies)

Review Highlights Progress and Validation Needs for AI in Digital Pathology

Pathology remains the gold standard for disease diagnosis, but clinical laboratories face growing demands for faster, more reproducible diagnostic and prognostic workflows. Digital pathology based on whole-slide... Read more

Industry

view channel
Image: Siemens Healthineers has begun carving out its in vitro diagnostics business as a standalone company named Olyrian Diagnostics (Photo courtesy of Siemens Healthineers)

Siemens Healthineers Begins Transition Toward Standalone Olyrian Diagnostics Business

Siemens Healthineers has begun carving out its in vitro diagnostics business, which will operate as Olyrian Diagnostics. The new name will be introduced in stages as the business prepares to become a standalone... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.